Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SGRY · against 331 other Healthcare companies of similar size
Ranked #329 of 332 · scores higher than 1% of peers · safety percentile 1
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)27 peers with a safety percentile of 0–9, including SGRY · Click a bar to see the companies
Mainly because of its beta, debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SGRY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 320 reported | 1.17× | 0.24× | 13% | 33% | |
| BetaLower is better · 318 reported | 1.92 | 0.58 | 6% | 33% | |
| Current ratioHigher is better · 319 reported | 1.95× | 2.82× | 33% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 2 | 2.6B USD | 100 | 43 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 1.8B USD | 99 | 42 | |
| 5 | 2.2B USD | 99 | 48 | |
| 325 | 4.6B USD | 3 | 61 | |
| 326 | 41.9B SEK (≈$4.2B) | 2 | 53 | |
| 327 | 2.0B USD | 2 | 27 | |
| 328 | 222.9B JPY (≈$1.5B) | 2 | 53 | |
| 329 | 3.0B USD | 1 | 39 | |
| 330 | 1.6B USD | 1 | 7 | |
| 331 | 2.9B USD | 1 | 50 | |
| 332 | 6.0B USD | 1 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score